Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06735599 · ClinicalTrials.gov registry record · NA

Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure

A NA study of Overweight and Oxidative Stress, sponsored by Georgia State University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06735599: Recruiting NA study of Overweight and Oxidative Stress, sponsored by Georgia State University.

NCT06735599 is a NA study of Overweight and Oxidative Stress that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 80 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06735599, a NA study of Overweight and Oxidative Stress, is actively recruiting participants, sponsored by Georgia State University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.

Primary Outcome

Assessment of whole-day ambulatory blood pressure during daytime and nighttime periods.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Wild Blueberry

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-17
Est. Completion 2026-01-01
Phase NA
Georgia State University

45 total trials

What NCT06735599 shows while recruiting

NCT06735599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (94% lower).

The record links to 10 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06735599 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06735599 about?

NCT06735599 is a clinical study titled "Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure". The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.

What is the current status of trial NCT06735599?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-17. Estimated completion is 2026-01-01.

What conditions does trial NCT06735599 study?

This clinical trial studies the following conditions: Overweight, Oxidative Stress, Cognition, High Blood Pressure, Diet.

What interventions are being tested in trial NCT06735599?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Wild Blueberry (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06735599?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06735599 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06735599's enrollment target sits among peer trials

80 120th of 197 higher than 76 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06735599, the US trial registry maintained by the National Library of Medicine. NCT06735599 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.